Logo - springer
Slogan - springer

Medicine - Internal Medicine | Experimental Hematology & Oncology

Experimental Hematology & Oncology

Experimental Hematology & Oncology

Editor-in-Chief: Z. Li; D. Liu; K. Wu
Managing Editor: Chung-Tsen Hsueh

ISSN: 2162-3619 (electronic version)

Journal no. 40164

BioMed Central

Open access BioMed Central
Learn more about the metrics of this journal
  • High quality peer-review service with a time to first decision of less than 32 days
  • Companion journal to Journal of Hematology & Oncology
  • Expert international Editorial Board

Experimental Hematology & Oncology publishes preclinical, basic, patient-oriented and translational research in all areas of hematology and oncology. The journal acts as an international platform for sharing laboratory findings and makes a deliberate effort to publish clinical trials with 'negative' results, as well as basic science studies with provocative findings. This peer-reviewed, open access journal offers impressive turnaround times with a time to first decision of less than 30 days.

Related subjects » Internal Medicine - Oncology & Hematology

Abstracted/Indexed in 

PubMedCentral, SCOPUS, EMBASE, Chemical Abstracts Service (CAS), Google Scholar, CNKI, DOAJ, EBSCO Academic Search, EBSCO Discovery Service, Emerging Sources Citation Index, Health Reference Center Academic, INIS Atomindex, OCLC WorldCat Discovery Service, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

Read This journal on BioMed Central

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Experimental Hematology & Oncology is an open access journal that encompasses all aspects of hematology and oncology with an emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.

    Experimental Hematology & Oncology publishes original work, hypothesis, commentaries and timely reviews. With open access and rapid turnaround time from submission to publication, the journal strives to be a hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the closely related fields of hematology and oncology.

  • Submit Online
  • Writing Resources: Training for Authors